title: Mitoxantrone-cyclophosphamide-fluorouracil-combination chemotherapy in metastatic breast cancer. 3-Year-follow-up.
authors.affiliation: Department of Internal Medicine, Section of Medical Oncology, Cerrahpaşa Medical Faculty, Istanbul, Turkey.
authors.forename: E
authors.initials: E
authors.lastname: Büyükünal
authors.forename: U
authors.initials: U
authors.lastname: Derman
authors.forename: S
authors.initials: S
authors.lastname: Serdengeçti
authors.forename: B
authors.initials: B
authors.lastname: Berkarda
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003520:Cyclophosphamide / Q000493:pharmacokinetics; D005260:Female; D005472:Fluorouracil / Q000493:pharmacokinetics; D005500:Follow-Up Studies; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D008942:Mitoxantrone / Q000493:pharmacokinetics; D013997:Time Factors
chemical_list: D003520:Cyclophosphamide; D008942:Mitoxantrone; D005472:Fluorouracil